Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.18 USD | -7.96% | -11.71% | +22.80% |
Mar. 12 | Craig-Hallum Adjusts LifeMD's Price Target to $15 From $10, Maintains Buy Rating | MT |
Mar. 12 | Cantor Fitzgerald Adjusts Price Target on LifeMD to $11 From $9, Maintains Overweight Rating | MT |
Evolution of the average Target Price on LifeMD, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering LifeMD, Inc.
Craig-Hallum | |
Cantor Fitzgerald | |
B. Riley | |
HC Wainwright | |
BTIG |
EPS Revisions
- Stock
- Equities
- Stock LifeMD, Inc. - Nasdaq
- Consensus LifeMD, Inc.